Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.

Abstract

A topical capsaicin cream decreases postsurgical neuropathic pain and, despite some toxicities, is preferred by patients over a placebo by a three-to-one margin among those expressing a preference.